These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8989824)

  • 1. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV; Bishop PD
    Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
    Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of substrate specificity for factor XIII.
    McDonagh J; Fukue H
    Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
    Mousa SA
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
    Aoki N
    Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.
    Greenberg CS; Shuman MA
    J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and coagulation proteins.
    Walsh PN
    Fed Proc; 1981 May; 40(7):2086-91. PubMed ID: 6785110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin αIIbβ3 and Fibrinogen.
    Kotova YN; Podoplelova NA; Obydennyy SI; Kostanova EA; Ryabykh AA; Demyanova AS; Biriukova MI; Rosenfeld MA; Sokolov AV; Chambost H; Kumskova MA; Ataullakhanov FI; Alessi MC; Panteleev MA
    Thromb Haemost; 2019 Jun; 119(6):906-915. PubMed ID: 30934104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets.
    Niemann S; Spehr N; Van Aken H; Morgenstern E; Peters G; Herrmann M; Kehrel BE
    Circulation; 2004 Jul; 110(2):193-200. PubMed ID: 15197141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets: physiology and biochemistry.
    Jurk K; Kehrel BE
    Semin Thromb Hemost; 2005; 31(4):381-92. PubMed ID: 16149014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII.
    Rubens FD; Perry DW; Hatton MW; Bishop PD; Packham MA; Kinlough-Rathbone RL
    Thromb Haemost; 1995 May; 73(5):850-6. PubMed ID: 7482415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.